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THE PREPARATION OF MACROCYCLIC LIGANDS FOR USE IN THE 
SYNTHESIS OF OXYGEN CARRIERS 
Katie Pelz and Rebecca Roesner* 
Department of Chemistry, Illinois Wesleyan University 
Extensive research has been pursued in the area of developing synthetic oxygen carriers. 
There have been numerous successful molecules already synthesized, many of which are 
structurally and functionally similar to the active sites of hemoglobin and myoglobin, 
which occur naturally in blood. Hemoglobin serves as a model for these syntheses 
because of its natural oxygen transport ability. At the hemoglobin active site, dioxygen 
binds reversibly to an iron metal center in the oxygen rich environment of the lungs. The 
oxygen is then carried through the blood to areas in the body that are low in oxygen, such 
as the muscles. Synthetic forms of these molecules are of considerable interest for use in 
applications in dioxygen purification and enrichment, oxygen storage and transportation, 
and possibly even in production of synthetic blood. By designing these molecules with 
certain electron donating substituents, it is possible to control and adjust the redox 
potential of the metal center to alter its reactivity. This will dictate how well the oxygen 
is able to bind reversibly to the metal center. A delicate balance of the electronic 
properties of the metal is required for reversible dioxygen binding. If the potential on the 
metal is too positive, the dioxygen molecule fails to bind to the metal. On the other hand, 
if the potential is too negative, dioxygen will bind irreversibly. It is also important to 
design a molecule with adequately sized ligand substituents to eliminate autoxidation, 
which is a process in which the dioxygen binds to another metal center, producing a 
metal-oxygen-metal 'sandwich'. With all of this in mind, we have attempted to design 
macrocyclic ligands with sufficiently bulky and electron donating substituents. These 
macrocycles are a precursor to the final product of the oxygen carrier in that the metal has 
not yet been introduced. 
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